Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 1.500% 9/1
-
Number of holders
-
12
-
Total 13F principal, excl. options
-
259,449,591
-
Principal change
-
0
-
Total reported value, excl. options
-
$309,774,451
-
Value change
-
+$582,114
-
Number of buys
-
5
-
Number of sells
-
3
-
Price
-
$1.04
Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q3 2024
As of 30 Sep 2024 PTC THERAPEUTICS INC - NOTE 1.500% 9/1 had 12 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $259,449,591 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included FRANKLIN RESOURCES INC, D. E. Shaw & Co., Inc., Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, STEELHEAD PARTNERS LLC, WHITEBOX ADVISORS LLC, Verition Fund Management LLC, ARISTEIA CAPITAL, L.L.C., and BlackRock, Inc..
This table shows 12 bond principal holders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.